Greater likelihood of remission in rheumatoid arthritis patients treated earlier in the disease course: Results from the Consortium of Rheumatology Researchers of North America registry

Interpreting registry-derived drug studies: Does societal context matter?

(2009) Joel M. Kremer et al.   ARTHRITIS AND RHEUMATISM

The role of drug and disease registries in rheumatic disease epidemiology

(2009) Joel M Kremer et al.   CURRENT OPINION IN RHEUMATOLOGY

Remission achieved after 2 years treatment with low-dose prednisolone in addition to disease-modifying anti-rheumatic drugs in early rheumatoid arthritis is associated with reduced joint destruction still present after 4 years: an open 2-year continuation study

(2008) I Hafstrom et al.   ANNALS OF THE RHEUMATIC DISEASES

An explanation for the apparent dissociation between clinical remission and continued structural deterioration in rheumatoid arthritis

(2008) A. K. Brown et al.   ARTHRITIS AND RHEUMATISM

Adalimumab response in patients with early versus established rheumatoid arthritis: DE019 randomized controlled trial subanalysis

(2008) Shahin Jamal et al.   CLINICAL RHEUMATOLOGY

Comparison of methotrexate monotherapy with a combination of methotrexate and etanercept in active, early, moderate to severe rheumatoid arthritis (COMET): a randomised, double-blind, parallel treatment trial

(2008) Paul Emery et al.   LANCET

Effects of switching between anti-TNF therapies on HAQ response in patients who do not respond to their first anti-TNF drug

(2008) K. L. Hyrich et al.   RHEUMATOLOGY